Medical/Pharmaceuticals
Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026
* Sacituzumab tirumotecan (sac-TMT)(佳泰莱®) plus pembrolizumab versus pembrolizumab as first-line treatment for PD-L1 positive advanced NSCLC: Results from the randomized, controlled, registrational Phase III OptiTROP-Lung05 study (Abstract #8506) * Efficacy and safety of lunbotinib fumarate (A...
2026-05-22 08:00
5749
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
TAIPEI, May 21, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy ofTSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected for presentation at the American Society of Clinic...
2026-05-22 05:34
4309
Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS
CHENGDU, China, May 21, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study (OptiTROP-Breast03) of the Company's tropho...
2026-05-21 22:08
6668
Guangzhou Lupeng/Newave Pharmaceutical Inc. Enrolled the First Patient in the Global Phase 3 ROCKET-CLL Trial Evaluating Rocbrutinib (LP-168) vs. Pirtobrutinib in R/R CLL/SLL
Head-to-Head Study Highlights Rocbrutinib as the World's First Fourth-Generation Dual Covalent and Non-Covalent BTK Inhibitor Designed to Overcome Resistance Mutations GUANGZHOU, China and SAN FRANCISCO, May 21, 2026 /PRNewswire/ -- Lupeng Pharmaceutical Ltd, a global clinical-stage biopharmaceu...
2026-05-21 22:00
5585
Neurophet Appoints Globally Renowned Imaging AI Expert Dr. Lawrence N. Tanenbaum as Scientific Advisor
* Former Vice President and Chief Technology Officer of RadNet, one of the largest outpatient imaging providers in the United States * Appointment expected to strengthen clinical validation, global expansion, and competitiveness in neuroimaging AI SEOUL, South Korea, May 21, 2026 /PRNewswire/...
2026-05-21 21:00
7603
Wincomm Secures Computex Best Choice Award for Three Consecutive Years (2024-2026), Leading the Future of AI-Powered Medical Solutions
HSINCHU, May 21, 2026 /PRNewswire/ -- Wincomm Corporation, a global leader in medical and industrial computing, is proud to announce it has achieved a prestigious milestone by winning the Computex Best Choice Award (BC Award) for three consecutive years from 2024 to 2026. This hat-trick of accola...
2026-05-21 15:16
4420
Singapore Court of Appeal Notes No Finding of Fraud Against KBP or Dr. Huang; Dispute with Novo Nordisk Undergoing Arbitration Proceedings
SINGAPORE, May 21, 2026 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company " or "KBP") today issued a statement addressing the decision by the Singapore Court of Appeal to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua ("Dr. Huang"), pending final res...
2026-05-21 08:52
5566
Hyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"
* Ebola IC50 (0.125μM)—Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM). * Clinical safety confirmed through COVID-19 and Dengue clinical trials. * Class-wide efficacy proven by accumulated research data for Hantavirus treatment. * Davey Smit...
2026-05-21 08:38
4296
Dimora Medical Launches Advanced Sacrum Silicone Absorbent Dressing to Enhance Pressure Injury Care
NEW YORK, May 20, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has introduced its new Sacrum Silicone Absorbent Soft Dressing, expanding its portfolio of home-based medical care solutions with a product designed to improve the management of pressu...
2026-05-21 01:50
4095
DeepQure Announces Robust 3-Month Results from HERO-HTN Clinical Study at EuroPCR 2026
PARIS, May 20, 2026 /PRNewswire/ -- DeepQure, a clinical-stage medical device company, today announced robust 3-month clinical data from its HERO-HTN-FIH study during a featured presentation at EuroPCR 2026. The interim results demonstrate that the HyperQure™ extravascular renal denervation (RDN)...
2026-05-20 22:00
4869
United Imaging Highlights uMR Jupiter 5T and uMR Ultra, along with the latest MRI advancements at ISMRM 2026
CAPE TOWN, South Africa, May 20, 2026 /PRNewswire/ -- United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare solutions, showcased its comprehensive MRI portfolio, highlighting significant advancements across multiple fronts Ultra-High Fie...
2026-05-20 22:00
5320
Sanyou Bio Launches SAI-DA 1.0, the AI-Drug Accelerator
SHANGHAI, May 20, 2026 /PRNewswire/ -- Sanyou Bio today announced the launch of SAI-DA 1.0 (Sanyou AI-Drug Accelerator). The platform builds on the company's AI-STAL (AI Super-Trillion Antibody Library), which serves as a vast molecular resource bank of super-trillion-scale molecules, SAI-DA 1.0 ...
2026-05-20 22:00
4563
Evolve Beyond Limits: YIZUMI CONNECT 2026 Showcases
FOSHAN, China, May 20, 2026 /PRNewswire/ -- Following its presence at CHINAPLAS 2026 in Shanghai, YIZUMI brought its latest vision for advanced molding and smart manufacturing to YIZUMI CONNECT 2026 in Nanxun, forming a twin-city platform linking the two events. YIZUMI CONNECT 2026: Full-Process...
2026-05-20 21:00
4295
Pictor and Disease Research Limited Formalise Collaboration to Advance Johne's Disease Monitoring Across New Zealand
Building on a two-year scientific collaboration and co-authored peer-reviewed publication, the collaboration supports new approaches to herd health monitoring for New Zealand's dairy and beef sectors AUCKLAND, New Zealand, May 20, 2026 /PRNewswire/ -- Pictor, a global targeted proteomics platfor...
2026-05-20 20:56
3341
NCCN Affirms Commitment to Cancer-Related Distress Resources Worldwide During Mental Health Awareness Month
The latest version of the National Comprehensive Cancer Network's Distress Thermometer and Problem List is available for free in more than 70 languages. PLYMOUTH MEETING, Pa., May 20, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—an...
2026-05-20 20:03
4542
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Study now open for enrollment at leading academic medical centers CARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today announced the initiation of a Phase I, first-in-hu...
2026-05-20 20:00
3721
METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026
BEIJING, HANGZHOU, China and CAMBRIDGE, Mass., May 20, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a global leader in AI-powered drug delivery innovation, today announced that new preclinical data from its heart-targeted LNP program has been selected for a Late-Breaking oral presentation at the...
2026-05-20 18:57
4270
Celebrate National Physical Fitness & Sports Month: Breathe Better, Move Freely with Oxygen Support
NEW YORK, May 20, 2026 /PRNewswire/ -- May is National Physical Fitness &
Sports Month, a time to celebrate staying active and prioritizing health at
every stage of life.VARON
2026-05-20 14:32
3844
Hyundai Bioscience: "Able to Supply Antiviral Drug in Event of Ebola or Hantavirus Spread"
SEOUL, South Korea, May 20, 2026 /PRNewswire/ -- Hyundai Bioscience announced on May 19th that it can supply clinical trial doses of its broad-spectrum antiviral drug XAFTY® in response to growing global concern over infectious disease outbreaks caused by Ebola and hantavirus. Hyundai Bioscien...
2026-05-20 13:57
3572
WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization
TOKYO, May 20, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), recently hosted its third CRDMO Day in Tokyo, bringing together senior leaders and experts from Japan's biopharmaceutical industry, exchanging the ...
2026-05-20 13:44
4337
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 317 media titles]
2026-06-08 10:16
Visa Partners with OpenAI to Power the Next Generation of AI Commerce
[Picked up by 304 media titles]
2026-06-11 09:30Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 297 media titles]
2026-06-05 19:08
QuettaFlow Technologies Strengthens Global Strategic Alliance with Lead Wealth and Showcases VasEdge at COMPUTEX Taipei 2026
[Picked up by 294 media titles]
2026-06-11 10:00
DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Most Read
YY Group (NASDAQ: YYGH) Wins Prestigious HAPA Solutions Excellence Award, Validating Enterprise AI Marketplace Adoption in Southeast Asia
2026-06-05 19:37
11758
Tuniu Announces Unaudited First Quarter 2026 Financial Results
2026-06-05 18:00
10123
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
2026-06-05 21:13
10049
